Alpha Mark Advisors, LLC Pfizer Inc Transaction History

Alpha Mark Advisors, LLC

$288 Million
Q2 2024

A detailed history of Alpha Mark Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 1,703 shares of PFE stock, worth $50,664. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,703

Previous 1,053 61.73%

Holding current value

$50,664

Previous $29,000 65.52%

% of portfolio

0.02%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	BUY	$25.26 - $29.6 $16,419 - $19,240	650 Added 61.73%	1,703 $48,000
Q1 2024 Apr 18, 2024	SELL	$25.89 - $29.73 $16,828 - $19,324	-650 Reduced 38.17%	1,053 $29,000
Q4 2023 Jan 19, 2024	SELL	$26.13 - $33.94 $522 - $678	-20 Reduced 1.16%	1,703 $49,000
Q3 2023 Oct 31, 2023	SELL	$32.09 - $37.51 $13,670 - $15,979	-426 Reduced 19.82%	1,723 $57,000
Q2 2023 Jul 28, 2023	SELL	$36.12 - $41.79 $6,140 - $7,104	-170 Reduced 7.33%	2,149 $79,000
Q1 2023 May 04, 2023	BUY	$39.39 - $51.28 $12,801 - $16,666	325 Added 16.3%	2,319 $95,000
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $12,399 - $16,186	-297 Reduced 12.96%	1,994 $102,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $109,400 - $133,550	-2,500 Reduced 52.18%	2,291 $100,000
Q2 2022 Aug 11, 2022	SELL	$46.53 - $55.17 $697 - $827	-15 Reduced 0.31%	4,791 $251,000
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $9,607 - $11,904	-210 Reduced 4.19%	4,806 $249,000
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $8,346 - $12,372	-202 Reduced 3.87%	5,016 $296,000
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $3,611 - $4,638	92 Added 1.79%	5,218 $224,000
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $39,500 - $44,748	1,100 Added 27.32%	5,126 $201,000
Q1 2021 Apr 29, 2021	SELL	$33.49 - $37.77 $40,188 - $45,324	-1,200 Reduced 22.96%	4,026 $146,000
Q4 2020 Feb 01, 2021	BUY	$33.47 - $42.56 $60,246 - $76,608	1,800 Added 52.54%	5,226 $192,000
Q3 2020 Nov 06, 2020	BUY	$31.75 - $37.25 $25,400 - $29,800	800 Added 30.46%	3,426 $126,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $421 - $511	-14 Reduced 0.53%	2,626 $86,000
Q1 2020 Apr 24, 2020	BUY	$27.03 - $38.62 $3,081 - $4,402	114 Added 4.51%	2,640 $86,000
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $11,522 - $13,076	350 Added 16.08%	2,526 $99,000
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $4,516 - $5,856	-139 Reduced 6.0%	2,176 $78,000
Q1 2019 May 09, 2019	BUY	$37.5 - $41.2 $5,212 - $5,726	139 Added 6.39%	2,315 $98,000
Q3 2018 Nov 05, 2018	SELL	$34.47 - $41.81 $13,788 - $16,724	-400 Reduced 15.53%	2,176 $96,000
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $7,977 - $9,255	-250 Reduced 8.85%	2,576 $91,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $87,606 - $96,507	2,826	2,826 $101,000

Others Institutions Holding PFE

# of Institutions

3,218

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Mark Advisors, LLC with notifications on news.

Account

Alpha Mark Advisors, LLC Pfizer Inc Transaction History